These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 3104105)

  • 21. Retinoic acid upregulates human Langerhans cell antigen presentation and surface expression of HLA-DR and CD11c, a beta 2 integrin critically involved in T-cell activation.
    Meunier L; Bohjanen K; Voorhees JJ; Cooper KD
    J Invest Dermatol; 1994 Dec; 103(6):775-9. PubMed ID: 7798614
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantitation of cutaneous Langerhans' cells of sarcoidosis patients.
    Berman B; Fox JL; Teirstein AS
    Ann N Y Acad Sci; 1986; 465():250-9. PubMed ID: 3089102
    [No Abstract]   [Full Text] [Related]  

  • 23. Pemphigus vulgaris: results of treatment with gold as a steroid-sparing agent in a series of thirteen patients.
    Poulin Y; Perry HO; Muller SA
    J Am Acad Dermatol; 1984 Nov; 11(5 Pt 1):851-7. PubMed ID: 6439764
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of major histocompatibility class II antigens by Langerhans' cells in cervical intraepithelial neoplasia.
    Hughes RG; Norval M; Howie SE
    J Clin Pathol; 1988 Mar; 41(3):253-9. PubMed ID: 2834416
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [HLA class II in Mexican patients with pemphigus vulgaris: shared epitope for autoimmunity].
    Rangel-Gamboa L; Vega-Memije ME; Acuña-Alonzo V; Granados-Arriola J
    Gac Med Mex; 2016; 152(5):587-591. PubMed ID: 27792691
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quantitative and morphologic changes of Langerhans' cells after ultraviolet A irradiation of human epidermis.
    Liu HN; Muller SA; Schroeter AL
    Acta Derm Venereol; 1987; 67(5):411-6. PubMed ID: 2448992
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Langerhans' cell population studies with OKT6 and HLA-DR monoclonal antibodies in vitiligo patients treated with oral phenylalanine loading and UVA irradiation.
    Westerhof W; Groot I; Krieg SR; Bos JD; Cormane RH
    Acta Derm Venereol; 1986; 66(3):259-62. PubMed ID: 2426905
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Flow cytometrically-sorted residual HLA-DR+T6+ Langerhans cells in topical steroid-treated human skin express normal amounts of HLA-DR and CD1a/T6 antigens and exhibit normal alloantigen-presenting capacity.
    Ashworth J; Kahan MC; Breathnach SM
    J Invest Dermatol; 1989 Feb; 92(2):258-62. PubMed ID: 2783952
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CD68 positive epidermal dendritic cells.
    Petzelbauer P; Födinger D; Rappersberger K; Volc-Platzer B; Wolff K
    J Invest Dermatol; 1993 Sep; 101(3):256-61. PubMed ID: 8370961
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pemphigus foliaceus--successful treatment with adjuvant gold therapy.
    Walton S; Keczkes K
    Clin Exp Dermatol; 1987 Sep; 12(5):364-5. PubMed ID: 3128413
    [No Abstract]   [Full Text] [Related]  

  • 31. Normal and neoplastic Langerhans cells: phenotypic comparison with other types of macrophages.
    Ralfkiaer E; Stein H; Ralfkiaer N; Hou-Jensen K; Mason DY
    Adv Exp Med Biol; 1985; 186():1009-15. PubMed ID: 3876694
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Simultaneous detection of T6 and HLA-DR antigens distinguishes three cell subpopulations in dispersed normal human epidermal cells.
    Dezutter-Dambuyant C; Faure M; Schmitt D; Laquoi C; Thivolet J
    Immunol Lett; 1984; 7(4):203-7. PubMed ID: 6423529
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dendritic cells in cutaneous lupus erythematosus: a clue to the pathogenesis of lesions.
    Mori M; Pimpinelli N; Romagnoli P; Bernacchi E; Fabbri P; Giannotti B
    Histopathology; 1994 Apr; 24(4):311-21. PubMed ID: 8045520
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of monoclonal antibodies specific for T cell subsets in cutaneous disorders: II. Immunomorphological studies in blood and skin lesions.
    Schmitt D; Thivolet J
    J Clin Immunol; 1982 Jul; 2(3 Suppl):111S-119S. PubMed ID: 6982276
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gold sodium thiomalate treatment of pemphigus.
    Penneys NS; Eaglstein WH; Indgin S; Frost P
    Arch Dermatol; 1973 Jul; 108(1):56-60. PubMed ID: 4197772
    [No Abstract]   [Full Text] [Related]  

  • 36. [Interleukin 2 deficiency in pemphigus vulgaris].
    Blitstein-Willinger E; Stüttgen G
    Z Hautkr; 1986 Jan; 61(1-2):82-5. PubMed ID: 3082083
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Langerhans' cells and lymphocytic infiltrate in AIDS-associated Kaposi's sarcoma. An immunohistochemical study.
    Valcuende-Cavero F; Febrer-Bosch MI; Castells-Rodellas A
    Acta Derm Venereol; 1994 May; 74(3):183-7. PubMed ID: 7521102
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Local involvement of antigen-presenting cells and activated T cells in perilesional and clinically uninvolved skin in pemphigus vulgaris.
    Mashkilleyson N; Konttinen YT; Visa K
    Acta Derm Venereol; 1989; 69(5):424-8. PubMed ID: 2572110
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Class II antigen expression of epidermal Langerhans cells in renal allograft recipients.
    Jontell M; Gäbel H; Ohman SC; Brynger H
    Transpl Int; 1988 Dec; 1(4):186-9. PubMed ID: 3075481
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of HLA-DR molecules by keratinocytes, and presence of Langerhans cells in the dermal infiltrate of active psoriatic plaques.
    Gottlieb AB; Lifshitz B; Fu SM; Staiano-Coico L; Wang CY; Carter DM
    J Exp Med; 1986 Oct; 164(4):1013-28. PubMed ID: 2428913
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.